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Review Article
Quality of life of adult congenital heart disease patients:
a systematic review of the literature
Theodora Fteropoulli,1 Jan Stygall,1 Shay Cullen,2 John Deanfield,2 Stanton P. Newman1
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2
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Abstract Aims: This review explores the quality of life of adult congenital heart disease patients and the
relationship between disease severity and quality of life.Methods: We searched seven electronic databases and the
bibliography of articles. The 31 selected studies fulfilled the following criteria: adult population; quantitative;
assessment of quality of life and/or impact of disease severity on quality of life using validated measures; English
language. Data extraction forms were used to summarise the results. Results: There are evident methodological
limitations within the reviewed studies such as heterogeneous populations, designs, and quality of life
conceptualisations and measurements. Despite these problems, findings suggest that the quality of life of adult
congenital heart disease patients is compromised in the physical domain compared with their healthy
counterparts, whereas no differences were found in relation to the psychosocial and environmental/occupational
domain. Some severity variables appear to be significant correlates of quality of life and could be considered in a
future standardised classification of disease severity. Conclusion: The methodological limitations of past research
in relation to the definition and measurement of quality of life, the study designs, and disease severity
classifications need to be addressed in future studies in order to provide robust evidence and valid conclusions in
this area of study. This will enable the development of targeted interventions for the improvement of quality of
life in the adult population of congenital heart disease patients.
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A
PPROXIMATELY EIGHT IN 1000 CHILDREN ARE
born with congenital heart disease, with
approximately two-thirds requiring treat-
ment. Owing to advances in treatment, ,90% are
now expected to survive into adulthood compared
with 20% 50 years ago.1 This has resulted in an
estimated current population of 135,000 adult
congenital heart patients in England.2
Traditionally, the outcome in congenital heart
disease has been measured in terms of mortality and
functional status. There is an increasing recognition
that reliance on clinical measures in determining
outcomes is not sufficient as it fails to capture the
patients’ perspective.3 Consequently, interest has
turned to examining the quality of life of adult
congenital heart disease patients. Although a
universally accepted definition of quality of life
does not exist, it is usefully conceptualised in three
broad domains, namely, physical, psychosocial, and
environmental.
Research suggests that adult patients with
congenital heart disease, like other patients with
chronic conditions, are faced with physical health
issues and psychosocial challenges.4 A clear per-
spective of the evidence on adult congenital heart
disease patients’ quality of life is lacking. In order
to clarify evidence regarding the quality of life of
adult congenital heart disease patients, a systematic
review of the literature was conducted. The purpose
of the systematic review was fourfold:
> Describe the quality of life of adult patients with
congenital heart disease.
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040 5767; Fax: 144 207 040 0875; E-mail: Stanton.Newman.1@city.ac.uk
> Examine the evidence on the relationship
between disease severity variables and quality
of life.
> Identify the quality of the existing literature.
> Suggest areas for future investigations.
Methodology
In all, seven electronic databases – Science Direct,
Pubmed, PsycInfo, Amed, Embase, CINAHL Plus,
and Medline – were searched (see Supplementary
Figure S1). Owing to the fact that the research
domain is relatively new, a start date criterion was
not applied in the search, and all relevant articles
published until November, 2011 were reviewed.
A language criterion was applied as the team could
only review articles written in the English language.
Initial search terms used were specific, for example
‘‘quality of life AND GUCH’’, but as the search
did not retrieve many relevant articles it was
broadened by using various word combinations,
that is, (‘‘quality of life’’ OR ‘‘life satisfaction’’ OR
‘‘well being’’) AND (GUCH OR ACHD OR congenital
heart disease OR congenital cardiac disease OR congenital
heart defect OR congenital cardiac defect). Where
the search yielded too many results, additional
filter terms were used, for example AND adult.
In all, 31 articles met the following inclusion/
exclusion criteria, including three identified from
the reference lists.
Exclusion criteria
> Qualitative studies.
> Sample solely consisting of Marfan syndrome
patients.
> Abstract quality of life measures, for example
non-validated single-item measures or question
sets.
> Study of the effects of individual psychosocial
variables, for example anxiety, depression, coping,
on quality of life.
> Reviews and meta-analyses.
> Opinion articles, commentaries, and reports.
Inclusion criteria
> Quantitative studies.
> Adult congenital heart disease patients.
> Intention to measure quality of life concept.
> Quality of life description and/or how disease
severity variables influence quality of life.
> Validated measures of quality of life.
> English language.
These studies were reviewed by means of data
extraction forms (see Supplementary Table S1).
Results
A total of 31 studies were reviewed; 26 examined
the patients’ quality of life in comparison with the
general population and 22 examined the relation-
ship of disease variables with quality of life.
Demographics and methodology
The number of participants ranged from 22 to 912,
age ranged from 14 to 85 years, and gender was
roughly balanced (see Table 1). The majority of the
studies (23/31) included patients with a range of
diagnoses, seven included patients with a single
diagnosis, and one categorised patients in terms of
the treatment they received. Most studies had a
cross-sectional design, with two out of 31 studies
using a longitudinal design. All but four studies
included a comparison group of either normative
data or matched controls.
Quality of life assessment
A variety of quality of life instruments were
used (Table 1). Generic instruments included the
Short Form-36 Health Survey (SF-36, 17 studies),
TNO-AZL (TAAQOL, four studies), Sickness
Impact Profile (SIP, two studies), Brief World
Health Organisation Quality of Life assessment
(WHOQOL-Bref, two studies), Duke Health Pro-
file (one study), and Subjective Quality of Life
(SQoL, one study). Single-item generic quality of
life was assessed by the Linear Analogue Scale (LAS,
one study) and Satisfaction with Life Scale (SWLS,
one study). Disease-specific and individual measures
included the TNO-AZL Congenital Heart Disease
version (CHD-TAAQOL, two studies) and the
Schedule for the Evaluation of Individual Quality
of Life-Direct Weighting (SEIQoL-DW, one study),
respectively.
The heterogeneous nature of the measures hinders
the combination of findings. For the purpose of
describing the findings, the scales or sub-scales
of each instrument were categorised into three
broad domains, that is, physical, psychosocial, and
environmental/occupational quality of life (see
Supplementary Table S2). These domains included
all relevant scales from the instruments that were
measured in two or more studies.
Quality of life in adult congenital heart
disease patients
Table 2 presents the findings of 26 studies that
compared the quality of life of adult congenital
heart disease patients with the general healthy
population.
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Table 1. Demographic and methodological details of the studies.
Study Design Sample Comparison group QoL measure
Bol Raap et al (2007)5 Retrospective n5 28 (follow-up n5 25) Normative data TAAQOL
13 years follow-up
(QoL cross-sectional)
Mean age (at surgery): 34 (19–50) n5 4410
Gender: 15 male, 13 female
Diagnosis: all VSD
van den Bosch et al (2004)6 Cross-sectional n5 22 for QoL assessment (total n5 36) Normative data SF-36
Mean age (at operation): 12 (2–34)
Gender: 18 male, 18 female
Diagnosis: 21 TA, 9 DILV, 6 other
Bruto et al (2007)7 Prospective
(cross-sectional)
n5 912 Normative data SF-36
Mean age: 30 (611)
Gender: 474 male, 438 female
Diagnosis: obstructive lesions (79 COA, 67 AS), shunt lesions
(99 VSD, 55 ASD, 45 AVSD), 9 complex acyanotic, complex
cyanotic (169 TOF, 87 TGA) and other
Chen et al (2011)8 Prospective
(cross-sectional)
n5 289 Controls age- and
gender-matched
WHOQOL-Bref-Taiwan
Mean age: 33.2 (610.6)
Gender: 105 male, 184 female
Diagnosis: 86 ASDII, 64 VSD, 60 TOF*
Cohen et al (2010)9 Cross-sectional n5 27 Controls age- and
gender-matched
CHD-TAAQOL
Mean age: 68.6 (65.7, 60–87)
n5 27
Only symptoms subscale
Gender: 10 male, 17 female
Mean age: 69.9
(68.2, 60–78)
Diagnosis: all ASDII
Gender: 10 male,
17 female
Daliento et al (2005)10 Cross-sectional n5 54 Normative data SF-36
Mean age: 32 (64)
Gender: 24 male, 30 female
Diagnosis: all TOF
Ebenroth and Hurwitz (2007)11 Longitudinal 10 years
follow-up
n5 35 Normative data SF-36
Mean age: 25.4 (19–37) Only physical component
Gender: 23 male, 12 female
Diagnosis: all TGA
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Table 1. Continued
Study Design Sample Comparison group QoL measure
Gratz et al (2009)12 Cross-sectional n5 564 Normative data and
controls
SF-36
Median age: 24 (14–37)
n5 53Gender: 309 male, 255 female
Median age: 25 (14–57)Diagnosis: 32 cyanotic, 31 Fontan circulation, 98 TGA with
arterial switch, 38 TGA no arterial switch, 96 TOF, 47 Ebstein
anomaly, 33 PS/PR, 66 left heart obstruction AS/COA, 62
isolated shunt, 61 other
Gender: 33 male, 18 female
Hager and Hess (2005)13 Prospective
(cross-sectional)
n5 149 Normative data SF-36
Median age: 23.8 (14–59.8)
Gender: 89 male, 60 female
Diagnosis: 13 SV, 47 TGA, 9 CCTGA, 32 TOF, 7 COA, 3 AS,
6 PS, 7 Ebstein’s anomaly, 5 VSD, 3 ASD, 14 other
Immer et al (2005)14 Cross-sectional n5 233 (QoL-n5 154) Normative data SF-36
Mean age: 35 (616) Age- and gender-matched
Gender: n/a
Diagnosis: 125 ASD, 34 AVD/PVD, 21 COA, 17 TOF/TGA
(cyanotic), 7 CAVCD
Irtel et al (2005)15 Cross-sectional n5 67 Normative data SF-36
Median age: 25 (16–62) Age- and gender-matched
Gender: 39 male, 28 female
Diagnosis: 32 TGA, 35 TOF
Jefferies et al (2004)16 Cross-sectional n5 32 Normative data from two
studies age-matched
SF-36
Mean age: 27 (69)
Gender: 15 male, 17 female
Diagnosis: 17 acyanotic (3 ASD, 2 MVP, 2 Marfan, 3 VSD, 3 AS,
2 COA, 2 PS) and 15 cyanotic (4 TOF, 3 TGA, 5 SV, 2 Down
syndrome, 1 TA)
Kamphuis et al (2002a)17 Cross-sectional n5 82 with mild CHD Controls TAAQOL
Mean age: 24.6 (17–32) n5 361 (SF-36)
Gender: 31 male, 51 female n5 831 (TAAQOL)
Diagnosis: 20 VSD, 7 PS, 6 ASD, 6 AS, 3 BAV, 2 APVD, 1 MVP,
37 spontaneous resolution
Kamphuis et al (2002b)18 Cross-sectional n5 78 with complex CHD Controls age- and
gender-matched
TAAQOL
Mean age: 24.3 (18–32)
Gender: 44 male, 34 female n5 361 (SF-36)
Surgery type: 39 SRV, 23 conduit or MP, 11 SV, 5 POS n5 831 (TAAQOL)
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Table 1. Continued
Study Design Sample Comparison group QoL measure
Lane et al (2002)19 Cross-sectional n5 276 Normative data SF-36
Median age: 31 (16–85)
Gender: 41.7% male, 58.3% female
Treatment groups: 68 SC, 105 SCor, 23 SP, 70 ME, 10 IO
Loup et al (2009)20 Cross-sectional n5 153 Normative data age- and
gender-matched
SF-36
Mean age: 26 (611)
Gender: 94 male, 59 female
Diagnosis: 43 TOF, 59 TGA, 51 VSD
Lu et al (2010)21 Cross-sectional n5 62 Normative data SF-36
Median age: 28.5 (14–69)
Gender: 37 male, 25 female
Diagnosis: all TOF
Mokhles et al (2011)22 Cross-sectional n5 509 Normative data SF-36
Mean age: 19 (0–66)
(SF-36 Z14 years)
Gender: 301 male, 208 female
Diagnosis: 170 AVP, 152 TOF, 63 PA/PS or VSD, 51 DVAC with
PA or PS, 26 CAT, 26 PA/PS with IS, 3 AA with BH
Moons et al (2004)23 Cross-sectional n5 89 n/a LAS, SWLS and
CHD-TAAQOL for
determinants of QoL
Median age: 24 (20–26.5)
Gender: 52 male, 37 female
Diagnosis: 76.4% simple TGA, 23.6% complex TGA
Moons et al (2005)24** Cross-sectional n5 629 n/a LAS, SWLS and
SEIQoL-DWMedian age: 24 (18–66)
Gender: 378 male, 251 female
Diagnosis: 112 TOF, 108 VSD, 89 COA, 65 AS, 48 PS, 37 TGA,
170 other
Moons et al (2006)25** Cross-sectional n5 404 Controls age- and
gender-matched
LAS, SWLS and
CHD-TAAQOL for
determinants of QoL
Median age: 13 (18–56)
n5 404Gender: 221 male, 183 female
Median age: 23 (18–58)Diagnosis: 79 VSD, 68 TOF, 62 COA, 42 AS, 31 PS, 20 TGA,
17 mixed AVD, 17 ASDII, 15 MIn, 12 SV, 7 DORV, 34 other Gender: 221 male,
183 female
Muller et al (2010)26 Cross-sectional n5 58 Normative data SF-36
Median age: 27.9
Gender: 28 male, 30 female
Diagnosis: 23 PS group (9 DILV, 5 TGA, 5 CC TGA1VSD,
1 TA, 1 PA, 1 HLHS, 1 AVSD), 35 ES group (21 VSD, 9 ASD,
6 AVSD)
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Table 1. Continued
Study Design Sample Comparison group QoL measure
Rietveld et al (2002)27 Cross-sectional n5 82 n/a SF-36
Mean age: 30.2 (17–77)
Gender: 40 male, 42 female
Diagnosis: 13 mild CHD (small VSD, ASDII, mild PVS), 44 moderate
(COA, TOF, AS), 25 severe (Fontan, Rastelli, Mustard, IO)
Rose et al (2005)28 Cross-sectional n5 111 Normative data WHOQOL-Bref and GBB
Mean age: 33 (612)
Gender: 56 male, 55 female
Diagnosis: 21 TOF, 16 ASD, 12 VSD, 11 AS, 10 COA, 7 TGA,
6 AIn, 5 PR, 4 PDA, 4 ES, 15 other
Saliba et al (2001)29 Cross-sectional n5 67 Normative data Duke Heart profile
Enrolled5 89
Mean age: 22.7 (17–49)
Gender: 42 male, 47 female
Diagnosis: 35 TA, 13 MA, 24 DIV, 17 other
Simko and McGinnis (2003)30** Cross-sectional,
case–control
n5 124 Controls age-, gender-,
race- and socio-economic
status-matched
SIP
Mean age: 26.4
n5 124
Gender: 54 male, 70 female
Mean age: 26.5
Diagnosis: 23 TOF, 21 VSD, 11 COA, 20 TGA, 6 SV, 12 ASD,
7 TA, 10 AS, 14 PS
Gender: 54 male, 70 female
Simko and McGinnis (2005)31** Cross-sectional n5 124 Controls age- and
gender-matched
SIP
Mean age: 26 (68.5)
n5 124Gender: 54 male, 70 female
Mean age: 26.5Diagnosis: cyanotic (23 TOF, 20 TGA, 6 SV, 7 TA) and acyanotic
(21 VSD, 11 COA, 12 ASD, 10 AS, 14 PS) Gender: 54 male, 70 female
Ternestedt et al (2001)32 Longitudinal (20 and
30 years post surgery)
n5 26 n/a SQoL
Mean age: 28.7 (30 years: 38.7)
Gender: 15 male, 11 female
Diagnosis: 12 TOF, 14 ASD***
Vandekerckhove et al (2009)33 Cross-sectional n5 39 Normative data TAAQOL
Median age: 19.9 (15.8–28.1)
Gender: 29 male, 10 female
Diagnosis: 24 simple TGA, 7 TGA1VSD, 4 Taussig–Bing
anomaly, 4 TGA/VSD with AO
Winter et al (2008)34 Cross-sectional n5 47 Normative data age- and
gender-matched
SF-36
Mean age: 35 (21–69)
Gender: 20 male, 17 female
Diagnosis: all SRV (31 TGA, 16 CCTGA)
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Physical domain. Of the 22 studies, 17 reported
poorer physical functioning, whereas five studies
reported no differences between the patients and
the general population. Risk factors for poorer
functioning included younger age,7,22 female
gender,8 disease severity,12 and the presence of
arrhythmias.15 In all, eight out of 18 studies found
more role limitations due to physical problems,
whereas 10 out of 18 studies found no differences
between patients and the general population.
Risk factors for greater limitations were specific
treatment groups, that is, cured, corrected, and
inoperable – versus palliated and medical19 – and
arrhythmias.15 In all, four out of 21 studies reported
more pain in patients, 14 out of 21 reported no
differences, and three out of 21 reported less pain
than the general population. Risk factors for more
pain were being inoperable19 and arrhythmias.15 In
all, 15 out of 21 studies showed poorer general
health perception in patients, five found no
difference, and one found better general health
perception in patients than in the general
population. Risk factors were disease severity –
cyanosis, Fontan physiology12 – and arrhythmias.15
All (2/2) studies reported more symptoms in
patients than in controls. There was one (1/4)
study that indicated poorer gross motor functioning,
whereas three out of four found no difference. All
(4/4) studies reported no differences between patients
and controls in fine motor functioning. There was
one (1/4) study that reported poorer cognitive
functioning, whereas three out of four reported no
differences between patients and controls. With
regard to sleep, two out of five studies reported
poorer results for patients, whereas three out of five
found no difference.
Psychosocial domain. With regard to this domain,
seven out of 23 studies indicated compromised
psychological/mental functioning in patients, whereas
16 showed no difference. Risk factors for poorer
functioning were female gender,10 arrhythmias,15
and specific treatment groups, that is, being
inoperable and cured.19 More role limitations due
to emotional problems were reported in two out
of 17 studies, less limitations in one out of 17,
and no differences in 14 out of 17. Risk factors
for more limitations were arrhythmias15 and being
surgically cured.19 Out of 20 studies, seven
indicated lower vitality in patients, whereas
13 showed no difference. Risk factors included
arrhythmias15 and being inoperable and cured.19
All (4/4) studies indicated no differences in
happiness and sexual functioning between patients
and controls. In all, two out of 23 studies showed
reduced social functioning in patients, whereas
21 out of 23 showed no differences. Risk factorsTa
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Table 2. Quality of life in adult congenital heart disease patients in relation to the comparison group.
Physical QoL Psychosocial QoL
Environmental/
occupational
QoL
Physical
functioning
Role
physical Pain
General
health Symptoms
Gross
motor
functioning
Fine
motor
functioning
Cognitive
functioning Sleep
Psychological/
mental health
Role
emotional Vitality Happiness
Sexual
functioning
Social
functioning
Environment
and daily
activities
Bol Raap et al (2007)5 5 5 5 k k 5 5 5 5 5 5
van den Bosch et al (2004)6 k k 5 k k 5 5 5
Bruto et al (2007)7 k 5 m k 5 5 5 5
Chen et al (2011)8 k k 5 m
Cohen et al (2010)9 k
Daliento et al (2005)10 k 5 5 5 5 5 5 5
Ebenroth and Hurwitz (2007)11 k 5 5 k k 5
Gratz et al (2009)12 k 5 5 k 5 5 5 5
Hager and Hess (2005)13 k 5 5 k 5 5 k 5
Immer et al (2005)14 5 5 5 5 5 5 5 5
Irtel et al (2005)15 k k k k k k k k
Jefferies et al (2004)16 k k 5 k 5 5 5 5
Kamphuis et al (2002a)17 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5
Kamphuis et al (2002b)18 k k 5 k k 5 5 5 5 5 k 5 5 5 5
Lane et al (2002)19 k k k k k k k k
Loup et al (2009)20 5 5 5 5 5 5 5 5
Lu et al (2010)21 5 5 k k 5 5 5 5
Mokhles et al (2011)22 k 5 m k 5 m 5 5
Moons et al (2006)25 m
Muller et al (2010)26 k k 5 k 5 5 k 5
Rose et al (2005)28 k k k k 5
Saliba et al (2001)29 5 5 5 5 5
Simko and McGinnis (2003)30 k k k k
Vandekerckhove et al (2009)33 5 5 5 5 5 k k 5 5 5 5
Winter et al (2008)34 k k m k 5 5 5 5
Winter et al (2010)35 k k k k 5 5 5 5
Total 17k 8k 4k 15k 2k 1k 45 1k 2k 7k 2k 7k 45 45 2k 1k
55 105 145 55 35 35 35 165 145 135 215 45
3m 1m 1m 1m
k5 poorer QoL; m5 better QoL; 55 similar QoL (in relation to controls); blank5 not measured; QoL5 quality of life
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included arrhythmias15 and being inoperable, cured,
or corrected.19
Environmental/occupational domain. Out of six
studies, one reported more disability in environment
and daily activities in patients, four showed no
difference, and one indicated better environmental
circumstances compared with the controls.
Disease severity and quality of life
In all, 22 studies examined the association between
disease severity variables and quality of life (see
Table 3).
Cyanosis. In all, six out of nine studies reported
poorer quality of life in cyanotic patients, mainly in
physical quality of life, that is, physical functioning
and general health, whereas three showed no
difference.
Diagnosis. Of the seven studies assessing quality
of life by diagnosis, only one study34 reported better
quality of life in the severe group, for example
tetralogy of Fallot, than the structurally simpler
group, for example atrial septal defect, whereas
the majority (6/7) reported diminished quality of life
in the more complex diagnoses, for example single
ventricle, Fontan, Marfan syndrome, mainly in
relation to physical and environmental quality of life.
Exercise capacity. Of the six studies, five reported
an association between exercise capacity as measured
by peak oxygen uptake (VO2) and physical quality
of life that is, physical functioning, general health,
whereas one found no association.
Functional status. In all, four out of seven studies
found an association between functional status –
New York Heart Association, Ability, Warnes &
Somerville Indexes – and quality of life, that is,
physical functioning, environmental, whereas three
out of seven found no association.
Ventricular dysfunction. Ventricular dysfunction
was not found to be associated with quality of life in
four out of five studies, whereas one study reported
an association with physical quality of life.
Arrhythmias. Out of four studies, two reported
an association between arrhythmias and quality of
life – general health, role limitations due to
emotional problems – whereas two studies found
no association.
Treatment type. Of the two studies assessing
quality of life by treatment type, one reported
better quality of life in patients who were treated
with recent surgical techniques, that is, recent
arterial switch versus Mustard & Senning. Contrary
to expectations, the second study reported that
‘‘cured’’ (curative surgery) patients have poorer
quality of life, that is, mental health, social
functioning, than patients with corrections, that is,
further operation possibility, and medical patients,
that is, no surgery. Palliated – further operation
possibility – and medical patients were similar.
Inoperable patients had poorer quality of life than all
groups except for similar social functioning and
vitality to ‘‘cured’’ patients.
Severity. Few of the above and other studies
categorised disease severity in different ways (see
Table 4). In all, four out of eight studies reported
significant associations between severity – assessed
by diagnosis, objective physical index, cyanosis –
and mainly physical quality of life and four reported
no association, the latter measured severity by
diagnosis.
Discussion
The first objective of this review was to investigate
the quality of life of adult congenital heart disease
patients. The pattern of results indicated that there
is strong evidence that adult patients with
congenital heart disease experience reduced quality
of life in the physical domains, that is, reduced
physical functioning, poorer general health, and
more symptoms than the general population. These
conclusions are similar to a previous literature
review.36 Although these findings are likely to
reflect the position of adult congenital heart disease
patients, it raises an important issue regarding
expectations. Given that quality of life is patient-
reported, it is possible that the findings may reflect
a perceived lack of understanding, leading patients
to develop unrealistic expectations and misconcep-
tions about their physical functioning. An unclear
disease course may leave patients feeling uncertain
and insecure about their condition and prognosis.37
Although predicting a clear prognosis is difficult, it
may be important to review the information that is
provided by healthcare professionals to patients.
It is also important that in some domains of
physical quality of life, for example, pain, sleep,
gross/fine motor functioning, as well as psychosocial
and environmental/occupational quality of life,
results indicated that patients are not different
from the healthy population. The finding of no
impact on psychosocial functioning in the adult
patients with congenital heart disease has a number
of potential explanations. One is patients having a
strong sense of coherence about their condition
because growing up with congenital heart disease
made them understand, manage, and find meaning
in their experiences.38 Another possible explanation
is change in internal standards, values, and
priorities,39 that is, response shift. Patients may
develop different internal health values from
healthy individuals.40 In one of the reviewed
studies,7 younger patients reported poorer quality
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Table 3. Associations between severity variables and quality of life.
Physical QoL Psychosocial QoL
Environmental/
occupational
QoL
Physical
functioning
Role
physical Pain
General
health Symptoms
Gross motor
functioning
Fine motor
functioning
Cognitive
functioning Sleep
Psychological/
mental health
Role
emotional Vitality Happiness
Sexual
functioning
Social
functioning
Environment
and daily
activities
Cyanosis
Bruto et al (2007)7 Y Y – Y Y – Y Y
Jefferies et al (2004)16 Y Y – Y – – Y –
Lane et al (2002)19 Y Y Y Y Y – Y Y
Saliba et al (2001)29 Y – – – –
Gratz et al (2009)12 Y – – Y – – – –
Simko and McGinnis (2005)31 – – – Y
Daliento et al (2005)10 – – – – – – – –
Loup et al (2009)20 – – – – – – – –
Moons et al (2005)24 –
Diagnosis
Gratz et al (2009)12 – – – Y – – – –
Irtel et al (2005)15 – – – – Y – Y –
Muller et al (2010)26 Y – – – – – – Y
Saliba et al (2001)29 – – Y – –
Simko and McGinnis (2005)31 Y Y Y Y
Winter et al (2010)35 Y Y Y Y – – – –
Ternestedt et al (2001)32 Y Y Y
Exercise capacity
Gratz et al (2009)12 Y – – Y – – – –
Hager and Hess (2005)13 Y – – Y – – – –
Irtel et al (2005)15 Y Y Y Y – Y – –
Muller et al (2010)26 Y Y – Y – – Y –
Rose et al (2005)28 Y Y – – –
Ebenroth and Hurwitz (2007)11 – – – – – –
Functional status
Chen et al (2011)8 Y – – Y
Ebenroth and Hurwitz (2007)11 Y Y – – – –
Kamphuis et al (2002b)18 Y Y Y Y Y Y Y Y Y Y Y – Y Y Y
Moons et al (2005)24 Y
Rietveld et al (2002)29 – – – – – – – –
Cohen et al (2010)9 –
Daliento et al (2005)10 – – – – – – – –
Ventricular dysfunction
Lu et al (2010)21 Y Y Y Y – – – –
Moons et al (2005)24 –
Daliento et al (2005)10 – – – – – – – –
Ebenroth and Hurwitz (2007)11 – – – – – –
Irtel et al (2005)15 – – – – – – – –
Arrhythmias
Bruto et al (2007)7 – – – Y – Y – –
Irtel et al (2005)15 Y Y Y Y Y Y Y Y
Loup et al (2009)20 – – – – – – – –
Daliento et al (2005)10 – – – – – – – –
Treatment type
Loup et al (2009)20 – – – Y Y – Y –
Lane et al (2002)19 Y Y Y Y Y Y Y Y
Y5association with QoL; –5 no association with QoL; blank5 not measured; QoL5 quality of life
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of life compared with their peers, whereas older
patients reported normal quality of life. This may
signify redefinition of standards, values, and
priorities and modification of quality of life
expectations with increasing age. The lack of
differences in environmental/occupational quality
of life may signify that patients have no problems in
work, access to healthcare, or daily activities.
A few studies grouped patients based on various
severity factors. The findings indicate no differences
in quality of life between the severity groups that
used composite severity ratings, suggesting that
categorising patients in this way may reflect clinical
issues but may mask significant effects of individual
severity indicators. For instance, when cyanosis
was combined with other factors into a severity
classification, it did not associate with quality
of life, but when considered independently it
was found to associate with most quality of life
domains.9 Considering each variable individually,
the severity indicators that were associated with
quality of life were diagnosis, cyanosis, exercise
capacity, arrhythmias, and functional status. It
appears more valuable to assess the independent
impact of specific variables and their relation to
quality of life, rather than constructing a broader-
based categorisation such as severity.
There are numerous methodological issues that
are apparent in the research reviewed. One difficulty
is that by definition adult congenital heart disease
patients as a group will be heterogeneous. This is
exacerbated in some studies by the failure to
distinguish between different diagnostic categories.
Whereas some studies focused on single diagnoses,
others included different diagnoses. Bruto et al7
argued that it is over-simplistic to categorise
patients on the basis of initial diagnosis and native
anatomy, and that emphasis should be given to
disease course and patient characteristics. In general,
the heterogeneity makes for large variability and
difficulty in comparing studies. Mixed and unexpected
findings can also be attributed to methodological
weaknesses such as small sample sizes, cross-sectional
designs, and different quality of life measures and
diagnosis categorisations. Convenience sampling may
have increased type II error and selection biases.
The absence of a quality of life definition in the
reviewed studies is important because previous
studies report that patients distinguish between
quality of life – predominantly affected by
psychological functioning – and perceived health
status – affected by physical functioning.41 Evi-
dence suggests that quality of life should also be
distinguished from health-related quality of life, a
term to be used when illness is relevant, but this is
not always applied in the literature.42 A clear
definition of quality of life is needed to guide the
selection of the most appropriate measures. Moons
et al43 provide a review of methodological problems
around quality of life measurement in adult
congenital heart disease.
To address these methodological limitations,
future studies should include larger patient groups,
thus allowing generalisability of the findings.
Longitudinal studies will allow investigation of
quality of life changes at different time-points and
detection of associations between quality of life and
its determinants, as well as potential age differences.
Sound quality of life conceptualisation and mea-
surement is also suggested. Finally, more research
needs to be conducted towards a consensus regarding
disease severity classification.
Limitations
The studies’ heterogeneity challenged the synthesis
and comparison of findings. Application of stricter
inclusion criteria, however, would have subsequently
limited the number of studies, thus compromising
the generalisability of findings. Other psychosocial
factors that may influence quality of life, for example
coping, anxiety, depression, have not been reviewed,
Table 4. Disease severity and quality of life.
Study Severity measure Associations
Bruto et al (2007)7 Diagnosis, native cyanosis, surgery type (obstructive,
shunt, complex)
No
Moons et al (2004)23 Diagnosis (structural complexity) No
Moons et al (2005)24 Diagnosis (Task Force 1: mild, moderate, severe) No
Rietveld et al (2002)27 Diagnosis (cardiologist: mild, moderate, severe) No
Chen et al (2011)8 Diagnosis (Task Force 1: mild, moderate, severe) Physical QoL
Jefferies et al (2004)16 Cyanosis Physical QoL
Kamphuis et al (2002b)18 Cyanosis, arrhythmias, heart failure, residual defects
(objective physical index: score 0–4)
Gross motor and cognitive functioning
Simko and McGinnis (2005)31 Cyanosis Work
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as the plethora of evidence suggests the potential for
an independent review in this area.
Conclusion
The quality of life of adult patients with congenital
heart disease appears to be compromised in physical
domains and there are indicative disease severity
variables that may be included in a standardised
classification system of disease severity. Future
research needs to address important methodological
limitations of previous studies. Knowledge about
the patients’ quality of life and the influencing
factors can potentially lead to the development of
targeted interventions for the improvement of
quality of life in the adult population of congenital
heart disease patients.
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